Chemo Pharma Laboratories Ltd - 506365 - Outcome of Board Meeting
1.Considered and approved Standalone Audited Financial Results for the quarter and year ended 31st March, 2019 duly reviewed by the Audit Committee. 2.Considered and approved Statutory Auditors Report and Standalone Audited Financial Statements for the year ended 31st March, 2019 duly reviewed by the Audit Committee. 3.The Board took on record the Corporate Governance Exemption Certificate for the Quarter ended 31st March, 2019 as per Regulation 15 of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015, which came into force on 01st December, 2015 certifying that Paid up equity capital of the Company is below Rs. 10 Crores and Net worth is below Rs. 25 Crores as on 31/03/2019. 4.The Board took on record Shareholding Pattern for the Quarter ended 31st March, 2019 under Regulation 31 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. 5.The Board took on record Reconciliation of Share Capital Audit issued by M/s. S. K. Jain & Co., Practicing Company Secretary under Regulation 55A of Securities and Exchange Board of India (Depositories and Participants) Regulations, 1996 of the Listing Agreement. 6.The Board decided to convene Annual General Meeting of the Company on Tuesday, 27th August, 2019 at 04:00 p.m. at the Registered Office of the Company. 7.The Board also took on record Statement of Investors Complaints pursuant to the Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. 8. The Board took on record Compliance Certificate pursuant to the Regulation 7(3) of Securities Exchange Board of India (Listing Obligations and Disclosure requirements) Regulations, 2015. 9. The Board took on...27-05-2019